News | June 09, 2026
Mariska Hargitay launches Bristol Myers Squibb's Myeloma Awareness Campaign
The campaign places renewed focus on a disease that remains incurable despite major scientific advances
The campaign places renewed focus on a disease that remains incurable despite major scientific advances
Researchers say the results point to a potential shift in how obesity is treated—as a central disease driving multiple conditions, rather than a collection of separate problems
We are building the bridge between complex molecular data and everyday clinical decisions
The graduating cohort comprised seven batches across five specialized programs
The agreement underscores Roche’s commitment to advancing innovative therapies for blood cancers and other serious diseases
The approved product is therapeutically equivalent to Haldol tablets of Ortho McNeil Pharmaceutical
The addition of the Halcyon system represents a significant milestone in the hospital’s oncology services
Multi-target licensing agreement combines Stipple Bio’s epitope discovery platform with Lonza’s ADC technologies to develop targeted cancer treatments
Approval for generic version of Xeljanz enables immediate launch and strengthens Aurobindo’s U.S. portfolio with its 586th ANDA approval
Seasoned pharma leader recognized for driving sales excellence, marketing strategy, and business growth
Subscribe To Our Newsletter & Stay Updated
